Research
The School of Pharmacy is one of the UK's leading centres for research in Pharmacy and Pharmaceutical Sciences.
Overview
Our research focuses on making real-world improvements for patients through our expertise in pharmaceutical science and practice.
AREAS OF ACTIVITY
The School of Pharmacy is one of the UK's leading centres for research in Pharmacy and Pharmaceutical Sciences. We have five main research themes.
MAKING A DIFFERENCE TO SOCIETY
Our research focuses on making real-world improvements for patients through our expertise in pharmaceutical science and practice.
KEY PROJECTS
Our researchers contribute to global and interdisciplinary projects including iABC (Inhaled antibiotics in bronchiectasis and cystic fibrosis) and BREATH, a cross-border project.
START YOUR CAREER IN RESEARCH
Interested in PhD study in the school of Pharmacy? Browse our PhD opportunities using the link below
ATHENA SWAN SILVER AWARD
The School of Pharmacy at Queen’s University Belfast is committed to the Athena SWAN Charter and underpinning beliefs. In 2014, the School received a silver Athena SWAN Award. In 2019 our silver Athena SWAN Award was renewed until 2023 in recognition of our commitment and success in addressing gender equality, representation, progression and success for all our staff.
Latest Publications
Rate and efficiency of synthetic plastic degradation by microbes isolated from environments containing natural hydrophobic polymers
- Scott Coughlin
- Stephen Kelly
- Julianne Megaw
1H‐NMR‐based metabolomics reveals the preventive effect of Enteromorpha prolifera polysaccharides on diabetes in Zucker diabetic fatty rats
- Jie Chen
- Shuting Wang
- Fuchuan Guo
- Yupeng Gong
- Tianbao Chen
- Christopher Shaw
- Rencai Jiang
- Fang Huang
- Dai Lin
Leveraging novel innovative thermoresponsive polymers in microneedles for targeted intradermal deposition
- Sabrina Roussel
- Jakes Udabe
- Akmal Bin Sabri
- Marcelo Calderón
- Ryan Donnelly
The Kinetic and Thermodynamic Interplay of Polymer-mediated Liquid-Liquid Phase Separation for Poorly Water-soluble Drugs
5 March 2024Nanoencapsulation of MDM2 inhibitor RG7388 and class-I HDAC inhibitor entinostat enhances their therapeutic potential through synergistic antitumor effects and reduction of systemic toxicity
- Anas Abed
- Michelle Greene
- Alhareth A Alsa'd
- Andrea Lees
- Andrew Hindley
- Daniel Longley
- Simon McDade
- Christopher Scott